(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 106.86% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.37%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.21%.
Uniqure Nv's revenue in 2026 is $16,098,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $2,276,132,981, with the lowest QURE revenue forecast at $649,555,490, and the highest QURE revenue forecast at $8,020,021,870. On average, 15 Wall Street analysts forecast QURE's revenue for 2027 to be $6,838,216,059, with the lowest QURE revenue forecast at $1,605,505,080, and the highest QURE revenue forecast at $14,444,293,248.
In 2028, QURE is forecast to generate $8,287,022,442 in revenue, with the lowest revenue forecast at $2,462,157,969 and the highest revenue forecast at $15,958,755,510.